Cordis Corporation
Cordis Corporation Starts Pivotal Trial for ExoSeal Vascular Closure Device
Published in Law and Health Weekly, April 21st, 2007
Cordis Corporation, a worldwide leader in developing and manufacturing interventional vascular technology, announced the start of the pivotal trial for the ExoSeal(TM) Vascular Closure Device. The ECLIPSE Trial is a multicenter, non-blinded, randomized study designed to measure the safety and efficacy of the ExoSeal(TM) Vascular Closure Device versus manual compression to close vascular access sites in patients having undergone diagnostic or interventional procedures. The trial will encompass 400 patients from 18 medical centers across the United States.
On February 13, Principal Investigator Chiu Wong, M.D., Associate Professor of Medicine, New York-Presbyterian...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Proposed Public Stock Offering - Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals Files Shelf Registration Statement - Anesthesia
Research and Markets: Medical Device Company Intelligence Report Provides a Full Review of the Smiths Medical Medical Device Activities and Finances - AngioDynamics, Inc.
AngioDynamics Announces Plan to Launch NeverTouch VenaCure Product Line - Appriss, Inc.
Arkansas Counties Turn to Technology to Combat Meth Production - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
